Nayoung K D Kim
Overview
Explore the profile of Nayoung K D Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park E, Lee C, Kim N, Ahn Y, Park Y, Lee J, et al.
J Clin Med
. 2022 Jun;
11(11).
PMID: 35683636
In the original article [...].
2.
Okawa Y, Ebata N, Kim N, Fujita M, Maejima K, Sasagawa S, et al.
Oncotarget
. 2021 Jul;
12(15):1540-1552.
PMID: 34316332
Introduction: Treatment options for biliary tract cancer (BTC) are very limited. It is necessary to investigate actionable genes and candidate drugs using a sophisticated knowledgebase (KB) and characterize BTCs immunologically...
3.
Lee S, Choi H, Park M, Choi I, An J, Kim A, et al.
Exp Mol Med
. 2021 Jul;
53(7):1192-1204.
PMID: 34316018
Loss-of-function variant in the gene encoding the KCNQ4 potassium channel causes autosomal dominant nonsyndromic hearing loss (DFNA2), and no effective pharmacotherapeutics have been developed to reverse channel activity impairment. Phosphatidylinositol...
4.
Park J, Kim H, Son D, Kim N, Sung Y, Cho M, et al.
Cancers (Basel)
. 2021 Jul;
13(11).
PMID: 34205170
The aim of this study was to investigate the clinical utility of minimal specimens acquired from endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) and perform targeted deep sequencing as a prognosis prediction...
5.
Park S, Lee C, Ku B, Kim M, Park W, Kim N, et al.
BMB Rep
. 2021 Jun;
54(7):386-391.
PMID: 34154699
Owing to rapid advancements in NGS (next generation sequencing), genomic alteration is now considered an essential predictive biomarkers that impact the treatment decision in many cases of cancer. Among the...
6.
Park S, Kim A, Kim N, Park W, Kim J, Oh E
Parkinsonism Relat Disord
. 2021 May;
91:181-183.
PMID: 33994096
No abstract available.
7.
Kim M, Kim A, Park J, Kim J, Ahn J, Park W, et al.
Clin Neurol Neurosurg
. 2020 Oct;
199:106267.
PMID: 33080427
Introduction: Besides cerebellar ataxia, various other movement disorders, including dystonia, could manifest as main clinical symptoms in ataxia-telangiectasia (A-T). However, the clinical characteristics of dystonic A-T patients are not clearly...
8.
Hong T, Cha H, Shim J, Lee B, Chung J, Lee C, et al.
J Immunother Cancer
. 2020 Oct;
8(2).
PMID: 33077514
Background: Tumor mutational burden (TMB) measurement is limited by low tumor purity of samples, which can influence prediction of the immunotherapy response, particularly when using whole-exome sequencing-based TMB (wTMB). This...
9.
Kim M, Kim A, Kim J, Park J, Youn J, Ahn J, et al.
Parkinsonism Relat Disord
. 2020 Sep;
80:58-64.
PMID: 32961395
Background: Hereditary cerebellar ataxias exhibit heterogeneous phenotypes and genotypes. To date, advancement of next-generation sequencing technologies have identified many causative genes for ataxia in various population. In this study, whole-exome...
10.
Park E, Lee C, Kim N, Ahn Y, Park Y, Lee J, et al.
J Clin Med
. 2020 Jul;
9(6).
PMID: 32604935
Steroid-resistant nephrotic syndrome (SRNS) is one of the major causes of end-stage renal disease (ESRD) in childhood and is mostly associated with focal segmental glomerulosclerosis (FSGS). More than 50 monogenic...